Molecular immunology2022; 152; 1-13; doi: 10.1016/j.molimm.2022.09.013

The impact of Escherichia coli contamination products present in recombinant African horse sickness virus serotype 4 proteins on the innate and humoral immune responses.

Abstract: Transcriptome analysis was used to characterise the in vitro primary and secondary immune responses induced in horse peripheral blood mononuclear cells (PBMC) stimulated for 24 h with the individual recombinant proteins of a virulent AHSV serotype 4 (AHSV4) field isolate (rAHSV4 proteins) that were previously expressed in Escherichia coli (E. coli). The results showed that the E. coli contamination products greatly affected the innate and humoral immune response transcripts. Hence, the impact of E. coli contamination products present in the individual rAHSV4 proteins on the translational immune response was determined. The combined amplification effects of synergistic pattern recognition receptors (PRRs), TNF-α and IL-1β signalling induced potent pro-inflammatory responses that were too overwhelming for the anti-inflammatory cytokines and regulators to control. In addition to inducing robust B cell and antibody-mediated responses, lipopolysaccharide (LPS) activation of the innate-like B cells and subsequent polyreactive (natural) antibody responses could potentially contribute to endotoxin tolerance.
Publication Date: 2022-10-07 PubMed ID: 36215827DOI: 10.1016/j.molimm.2022.09.013Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers in this study utilized transcriptome analysis to assess the impacts of Escherichia coli (E. coli) contamination on the immune responses triggered by various proteins of African horse sickness virus serotype 4 (AHSV4) in horse peripheral blood cells.

Exploration of Immune Responses

  • The study firstly aimed to understand the primary and secondary immune responses generated by horse peripheral blood mononuclear cells (PBMC) when stimulated with individual recombinant proteins of AHSV serotype 4.
  • The AHSV4 proteins examined in the research, known as rAHSV4 proteins, were expressed in E. coli for the experiments.
  • Through the use of transcriptome analysis, a tool that allows for the examination of gene expression, the scientists were able to evaluate the changes that occurred in the immune response due to the stimulation by these proteins.

Impact of E. coli Contamination

  • The research found that the contamination products from E. coli greatly influenced the innate and humoral immune responses.
  • The innate immune response is the body’s first line of defense against pathogens, functioning immediately or within hours of an antigen’s appearance in the body. The humoral immune response, on the other hand, refers to antibody production and the accessory processes that accompany it, such as activation of B cells and helper T cells.
  • The researchers assessed the specific influence of these E. coli contamination products on the immune response, to understand the full extent of their impact.

Pro-inflammatory Responses and Endotoxin Tolerance

  • The data demonstrated that the amplification effects of synergistic pattern recognition receptors (PRRs), tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) signalling initiated strong pro-inflammatory responses.
  • These pro-inflammatory reactions were overwhelming and not adequately managed by anti-inflammatory cytokines and regulators, suggesting a detrimental effect on the body’s immune balance.
  • The study also found that lipopolysaccharide (LPS), a molecule found in the outer membrane of Gram-negative bacteria like E. coli, could activate ‘innate-like’ B cells and induce polyreactive (natural) antibody responses. This could potentially contribute to a state of endotoxin tolerance where the body develops a diminished response to endotoxins (harmful substances released when bacteria die and their cell walls disintegrate).

Cite This Article

APA
Faber E, Tshilwane SI, Van Kleef M, Pretorius A. (2022). The impact of Escherichia coli contamination products present in recombinant African horse sickness virus serotype 4 proteins on the innate and humoral immune responses. Mol Immunol, 152, 1-13. https://doi.org/10.1016/j.molimm.2022.09.013

Publication

ISSN: 1872-9142
NlmUniqueID: 7905289
Country: England
Language: English
Volume: 152
Pages: 1-13
PII: S0161-5890(22)00436-9

Researcher Affiliations

Faber, Erika
  • Agricultural Research Council-Onderstepoort Veterinary Research, Private Bag X5, Onderstepoort 0110, South Africa; Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa. Electronic address: FaberE@arc.agric.za.
Tshilwane, Selaelo Ivy
  • Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.
Van Kleef, Mirinda
  • Agricultural Research Council-Onderstepoort Veterinary Research, Private Bag X5, Onderstepoort 0110, South Africa; Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.
Pretorius, Alri
  • Agricultural Research Council-Onderstepoort Veterinary Research, Private Bag X5, Onderstepoort 0110, South Africa; Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.

MeSH Terms

  • Animals
  • Horses
  • African Horse Sickness Virus
  • African Horse Sickness
  • Escherichia coli
  • Leukocytes, Mononuclear
  • Serogroup
  • Immunity, Humoral
  • Escherichia coli Infections
  • Recombinant Proteins

Conflict of Interest Statement

Declaration of Competing Interest The authors declare that there is no conflict of interest.

Citations

This article has been cited 0 times.